The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule-a case series of 420 travelers

Journal of Travel Medicine

Volumn 18, Issue 5, 2011, Pages 327-332

  Mills, Deborah J ^a   Lau, Colleen L ^b,c   Fearnley, Emily J ^b   Weinstein, Philip ^b,d  

^a Dr Deb the Travel Doctor   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Travel Medicine Centre Perth   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; RABIES; SCHOOL CHILD; SEROCONVERSION; SEROLOGY; VACCINATION;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CHILD; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGENETICS; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; PROGNOSIS; RABIES; RABIES VACCINES; RETROSPECTIVE STUDIES; TRAVEL; VACCINATION; YOUNG ADULT;

EID: 80052454271     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2011.00540.x     Document Type: Article

References (16)

1. World Health Organization. Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 2010; 32: 309-320.
2. Steffen R., Chapter 2. Epidemiology: mortality and morbidity in travelers. In:, Keystone JS, Kozarsky PE, Freedman DO, et al., eds. Travel medicine. 2nd Ed. Edinburgh: Mosby, 2008: 5-11.
3. Phanuphak P, Ubolyam S, Sirivichayakul S., Should travellers in rabies endemic areas receive pre-exposure rabies immunization? Ann Med Interne (Paris) 1994; 145: 409-411.
4. National Health and Medical Research Council. Australian bat lyssavirus infection and rabies. In: The Australian immunisation handbook. 9th Ed. Canberra: Australian Government Department of Health and Ageing, 2009. Available at:. (Accessed 2011 Jul 20)
5. Manning SE, Rupprecht CE, Fishbein D, et al., Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57: 1-28.
6. Lau C, Sisson J., The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J Travel Med 2002; 9: 285-288.
7. Shaw MM, Leggat PA, Williams ML., Intradermal pre-exposure rabies immunisation in New Zealand. Travel Med Infect Dis 2006; 4: 29-33.
8. Gherardin A, Lau S., Intradermal rabies vaccine. Med J Aust 2007; 187: 58-59.
9. Roukens AH, Vossen AC, van Dissel JT, Visser LG., Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults. Vaccine 2008; 26: 3438-3442.
10. Khawplod P, Wilde H, Benjavongkulchai M, et al., Immunogenicity study of abbreviated rabies preexposure vaccination schedules. J Travel Med 2007; 14: 173-176.
11. Brown D, Featherstone JJ, Fooks AR, et al., Intradermal pre-exposure rabies vaccine elicits long lasting immunity. Vaccine 2008; 26: 3909-3912.
12. WHO expert consultation on rabies. World Health Organ Tech Rep Ser 2005; 931: 1-88, back cover.
13. Woldehiwet Z., Clinical laboratory advances in the detection of rabies virus. Clin Chim Acta 2005; 351: 49-63.
14. Khawplod P, Wilde H, Sriaroon C, et al., One or three intradermal injections within one week for rabies pre-exposure immunization. Dev Biol (Basel) 2008; 131: 393-401.
15. Jaijaroensup W, Limusanno S, Khawplod P, et al., Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination. J Travel Med 1999; 6: 234-237.
16. Shantavasinkul P, Tantawichien T, Wilde H, et al., Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 2010; 50: 56-60.